Delivery Order SPE2DB20D7061-SPE2DB25FSPR1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,554.70 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 21, 2025. This is a firm fixed-price, non-set-aside contract issued on August 20, 2025, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $8,469.84 under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,976.98 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of Annovera vaginal rings. This contract has an ultimate completion date of August 19, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for the provision...
- The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.98 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.04 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, indicating it flows from a larger indefinite delivery contract vehicle. The contraceptive product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,759.87 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed price contract. This award, issued on August 11, 2025, represents a non-competitive delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Annovera is a vaginal contraceptive ring indicated for prevention...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,120 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ANNOVERA vaginal rings. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have any set-aside...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPR1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,861.62 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a pediatric/women's health pharmaceutical product addition to the DLA's medical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical vendor for the DLA Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's federal contracting demonstrates significant capability in fulfilling competitive federal medical procurement across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/11/25 |